Drug Trial Radar · NCT00644358
A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD)
Last checked: Nov 20, 2026Latest source record: Sep 25, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
616
Actual
Start
Dec 31, 2007
Primary completion
May 31, 2009
Study completion May 31, 2009
Sponsor
- Lead sponsor
- Forest LaboratoriesAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Mar 26, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This open label 52-week clinical trial is designed to assess the safety and tolerability of vilazodone and to analyze genetic markers of response to vilazodone in adult patients diagnosed with MDD. This study will enroll approximately 600 patients.
Conditions
- Major Depressive Disorder
Interventions
vilazodoneDrug
titration to 40 milligrams (mg) every day (qd) for 1 year
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-Emergent Adverse Events (TEAEs)Time frame: From first dose of study medication and up to 30 days after the last dose of study medication (Up to 13 months)
Locations
38 sites in 1 country. Site status is shown where the registry gives one.
Collaborative Neuroscience Network, Inc.
Garden Grove, California
Affiliated Research Institute
San Diego, California
Collaborative Neuroscience Network, Inc
Torrance, California
Pacific Clinical Research
Upland, California
Radiant Research
Denver, Colorado
CNS Clinical Research Group
Coral Springs, Florida
Gulfcoast Clinical Research
Fort Myers, Florida
Sarkis Clinical Trials
Gainesville, Florida
Clinical Neuroscience Solutions, Inc
Jacksonville, Florida
Florida Clinical Research Center, LLC
Lady Lake, Florida
Clinical Neuroscience Solutions, PA
Orlando, Florida
Stedman Clinical Trials
Tampa, Florida
Carman Research
Smyrna, Georgia
Chicago Research Center
Chicago, Illinois
Capstone Clinical Research
Libertyville, Illinois
Davis Clinic
Indianapolis, Indiana
Vince and Associates Clinical Research
Overland Park, Kansas
Capital Clinical Research Associates
Rockville, Maryland
Summit Research Network
Farmington, Michigan
Radiant Research
St Louis, Missouri
Radiant Research
Las Vegas, Nevada
Bioscience Research, LLC
Mount Kisco, New York
Eastside Comprehensive Medical Center
New York, New York
The Medical Research Network, LLC
New York, New York
North Coast Clinical Trials
Beachwood, Ohio
Patient Priority Clinical Sites, LLC
Cincinnati, Ohio
North Star Medical Research, LLC
Middleburg Heights, Ohio
IPS Research Company
Oklahoma City, Oklahoma
Paramount Clinical Research
Bridgeville, Pennsylvania
Introspect of Buxmont
Colmar, Pennsylvania
Suburban Research Associates
Media, Pennsylvania
Clinical Neuroscience Solutions
Memphis, Tennessee
FutureSearch Trials
Austin, Texas
FutureSearch Trials
Dallas, Texas
Croft Group Research Center
San Antonio, Texas
Neuropsychiatric Associates
Woodstock, Vermont
Neuroscience, Inc.
Herndon, Virginia
Dominion Clinical Research
Midlothian, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.